Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Vilas G Jamakandi"'
Autor:
Fatima Sanjeri Dasankoppa, Pooja Solankiy, Hasanpasha N Sholapur, Vilas G Jamakandi, Vinuta M Sajjanar, Pooja M Walveka
Publikováno v:
Indian Journal of Health Sciences and Biomedical Research KLEU, Vol 10, Iss 3, Pp 323-330 (2017)
Background: The significant problem in the ocular drug delivery is the attainment of optimal drug concentration at the site of action. Development of therapeutic agents that require repeated long-term administration is a driver for the sustained rele
Externí odkaz:
https://doaj.org/article/a45d9600849b43c489ec270a2f4eae86
Publikováno v:
Indian Journal of Health Sciences and Biomedical Research KLEU, Vol 9, Iss 1, Pp 56-66 (2016)
Introduction: A major problem in ocular therapeutics is the attainment of optimum drug concentration at the site of action, which is compromised mainly due to precorneal loss resulting in only a small fraction of the drugs being absorbed. The effecti
Externí odkaz:
https://doaj.org/article/52db345d83aa43eba0192b6fd8270203
Autor:
Vinuta Mallikarjun Sajjanar, Fatima Sanjeri Dasankoppa, Vilas G Jamakandi, Hasanpasha N Sholapur, Pooja M Walveka, Pooja Solankiy
Publikováno v:
Indian Journal of Health Sciences and Biomedical Research KLEU, Vol 10, Iss 3, Pp 323-330 (2017)
Background: The significant problem in the ocular drug delivery is the attainment of optimal drug concentration at the site of action. Development of therapeutic agents that require repeated long-term administration is a driver for the sustained rele
Publikováno v:
Indian Journal of Health Sciences and Biomedical Research KLEU, Vol 9, Iss 1, Pp 56-66 (2016)
Introduction: A major problem in ocular therapeutics is the attainment of optimum drug concentration at the site of action, which is compromised mainly due to precorneal loss resulting in only a small fraction of the drugs being absorbed. The effecti